Healthcare provider profile · identity verified

Ryan Semko, D.O.

Family Practice · OAK RIDGE, TN · NPI 1881129443

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	390	123
Levothyroxine Sodium	Levothyroxine Sodium	278	84
Gabapentin	Gabapentin	253	53
Prednisone	Prednisone	222	147
Amlodipine Besylate	Amlodipine Besylate	219	67
Lisinopril	Lisinopril	215	62
Omeprazole	Omeprazole	192	56
Losartan Potassium	Losartan Potassium	162	53
Albuterol Sulfate Hfa	Albuterol Sulfate	160	57
Simvastatin	Simvastatin	138	35
Meloxicam	Meloxicam	136	63
Duloxetine Hcl	Duloxetine Hcl	132	30
Pantoprazole Sodium	Pantoprazole Sodium	125	46
Rosuvastatin Calcium	Rosuvastatin Calcium	123	42
Metoprolol Tartrate	Metoprolol Tartrate	119	33
Methocarbamol	Methocarbamol	117	57
Hydrochlorothiazide	Hydrochlorothiazide	116	36
Trazodone Hcl	Trazodone Hcl	104	39
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	102	89
Metformin Hcl Er	Metformin Hcl	102	35
Furosemide	Furosemide	100	42
Montelukast Sodium	Montelukast Sodium	97	24
Tramadol Hcl	Tramadol Hcl	95	33
Metformin Hcl	Metformin Hcl	93	30
Fluticasone Propionate	Fluticasone Propionate	91	36
Potassium Chloride	Potassium Chloride	87	28
Eliquis	Apixaban	85	17
Hydralazine Hcl	Hydralazine Hcl	85	23
Pravastatin Sodium	Pravastatin Sodium	79	21
Diclofenac Sodium	Diclofenac Sodium	75	39
Zolpidem Tartrate	Zolpidem Tartrate	73	15
Sertraline Hcl	Sertraline Hcl	72	17
Tamsulosin Hcl	Tamsulosin Hcl	68	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	67	13
Ozempic	Semaglutide	67	suppressed
Carvedilol	Carvedilol	59	19
Escitalopram Oxalate	Escitalopram Oxalate	59	19
Clopidogrel	Clopidogrel Bisulfate	58	12
Metoprolol Succinate	Metoprolol Succinate	58	18
Tizanidine Hcl	Tizanidine Hcl	57	16
Ezetimibe	Ezetimibe	56	17
Mirtazapine	Mirtazapine	56	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	20
Glipizide	Glipizide	55	19
Azithromycin	Azithromycin	54	50
Famotidine	Famotidine	52	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	13
Ondansetron Odt	Ondansetron	50	30
Clonazepam	Clonazepam	49	suppressed
Glimepiride	Glimepiride	49	16
Allopurinol	Allopurinol	48	15
Bumetanide	Bumetanide	48	16
Jardiance	Empagliflozin	48	suppressed
Mounjaro	Tirzepatide	48	suppressed
Alprazolam	Alprazolam	46	suppressed
Oxycodone Hcl	Oxycodone Hcl	46	suppressed
Pregabalin	Pregabalin	45	11
Lorazepam	Lorazepam	43	suppressed
Citalopram Hbr	Citalopram Hydrobromide	41	15
Doxycycline Hyclate	Doxycycline Hyclate	41	34
Buspirone Hcl	Buspirone Hcl	40	suppressed
Cephalexin	Cephalexin	39	32
Fluoxetine Hcl	Fluoxetine Hcl	39	14
Hydroxyzine Hcl	Hydroxyzine Hcl	39	11
Synthroid	Levothyroxine Sodium	39	suppressed
Alendronate Sodium	Alendronate Sodium	37	suppressed
Valsartan	Valsartan	37	suppressed
Benazepril Hcl	Benazepril Hcl	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Donepezil Hcl	Donepezil Hcl	35	11
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Promethazine Hcl	Promethazine Hcl	32	13
Amitriptyline Hcl	Amitriptyline Hcl	30	11
Baclofen	Baclofen	29	suppressed
Fluconazole	Fluconazole	29	13
Ramipril	Ramipril	29	11
Clonidine Hcl	Clonidine Hcl	27	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Diazepam	Diazepam	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	17
Propranolol Hcl	Propranolol Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Nystatin	Nystatin	23	suppressed
Atenolol	Atenolol	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	15
Meclizine Hcl	Meclizine Hcl	22	13
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Mupirocin	Mupirocin	21	20
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Finasteride	Finasteride	20	suppressed
Levofloxacin	Levofloxacin	20	19
Temazepam	Temazepam	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	17
Aripiprazole	Aripiprazole	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Sucralfate	Sucralfate	17	12
Glyburide	Glyburide	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Cefdinir	Cefdinir	15	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Naproxen	Naproxen	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Testosterone	Testosterone	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	11
Xarelto	Rivaroxaban	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Fetzima	Levomilnacipran Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Praluent Pen	Alirocumab	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	11
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Repatha Syringe	Evolocumab	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error